Dogwood Therapeutics (DWTX)

• Market cap: $60.2M
• 1 day: -1.1%
• 5 days: -9.14%
• 1 month: 16.99%
• 3 months: -34.91%
• 6 months: -71.18%
• Year to date: -57.78%
• 1 year: -66.23%
• 5 years: -98.71%
• 10 years: -99.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Employees: 8